SCHEMBL20179598

SCHEMBL20179598

COc1cc(CCc2cccc(O)c2)cc(OC)c1

nearest known ligand 0.90

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.90
GABRG2 P18507 1/20 0.90
GABRB3 P28472 1/20 0.90
GABRA3 P34903 1/20 0.90
GABRA2 P47869 1/20 0.90
GABRB2 P47870 1/20 0.90
CALM1 P0DP23 6/20 0.62
AKR1B1 P15121 2/20 0.62
PTPN1 P18031 1/20 0.58
NOS2 P35228 1/20 0.58
ABL1 P00519 1/20 0.53
BCR P11274 1/20 0.53
POLB P06746 1/20 0.53
ABCB1 P08183 1/20 0.52
TAAR1 Q96RJ0 2/20 0.52
DRD2 P14416 1/20 0.52
DRD1 P21728 1/20 0.52
CYP19A1 P11511 1/20 0.51
CHRM2 P08172 1/20 0.51
CHRM1 P11229 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Batatasin Iii SCHEMBL29629601 0.95 GABRA1 (1.00) GABRA1GABRG2GABRB3GABRA3GABRA2
Batatasin Iii SCHEMBL29352616 0.95 GABRA1 (1.00) GABRA1GABRG2GABRB3GABRA3GABRA2
Batatasin Iii SCHEMBL11505373 0.95 GABRA1 (1.00) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL27968568 0.91 GABRA1 (0.81) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL30574244 0.88 GABRA1 (0.87) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL27968433 0.86 GABRA1 (0.73) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL1975466 0.85 TAAR1 (0.69) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL11504762 0.82 GABRA1 (0.78) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL30007868 0.81 CALM1 (0.66) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL18563067 0.81 CALM1 (0.66) GABRA1GABRG2GABRB3GABRA3GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4496567-A1 USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS Chang Gung University (TW) 2025-01-29 EP claimed
WO-2023178592-A1 USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS CHANG GUNG UNIVERSITY (CN) 2023-09-28 WO claimed
EP-4496567-A1 USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS Chang Gung University (TW) 2025-01-29 EP disclosed
EP-4496567-A1 USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS Chang Gung University (TW) 2025-01-29 EP disclosed
WO-2023178592-A1 USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS CHANG GUNG UNIVERSITY (CN) 2023-09-28 WO disclosed
WO-2023178592-A1 USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS CHANG GUNG UNIVERSITY (CN) 2023-09-28 WO disclosed
WO-2018090805-A1 SKIN-PROTECTION COMPOSITION CONTAINING DENDROBIUM-BASED INGREDIENTS HONG KONG BAPTIST UNIVERSITY (CN) 2018-05-24 WO disclosed